What happens when two leading computational biologists swap code and models for a lively conversation? Fabian Theis, a pioneer in single-cell and AI-driven biomedical research, joins Shai for a fascinating exchange about: — The single-cell revolution and how it’s reshaping the industry. — The promise (and hype) of foundational models. — And why tomorrow’s R&D lab might be a “virtual biotech” — or even a one-person operation!

What happens when two leading computational biologists swap code and models for a lively conversation?Fabian Theis, a pioneer in single-cell and AI-driven biomedical research, joins Shai for a fascinating exchange about:— The single-cell revolution and how it’s reshaping the industry.— The promise (and hype) of foundational models.— And why tomorrow’s R&D lab might be a “virtual biotech” — or even a one-person operation!

What happens when two leading computational biologists swap code and models for a lively conversation? Fabian Theis, a pioneer in single-cell and AI-driven biomedical research, joins Shai for a fascinating exchange about: — The single-cell revolution and how it’s reshaping the industry. — The promise (and hype) of foundational models. — And why tomorrow’s R&amp;D lab might be a “virtual biotech” — or even a one-person operation!

Season 3 - Episode 2 - The Single Cell Revolution - Prof. Fabian Theis

In a big-data age, drug development needs to be reinvented. The data revolution is already taking place in finance and commerce, in agriculture and transportation. There’s no reason for pharma to stay behind. “Tech on Drugs” is a podcast about the future of pharma. From novel targets to novel biomarkers. From disease models to population models. From clinical trials to synthetic trials. It’s a show about the doctor in the clinic who needs to build on molecular features and about the bioinformatician in the lab who needs to build on clinical endpoints. In each episode, our host, Prof. Shai Shen-Orr, gets to do what he loves to do most. He gets to speak with some of the world’s top scientists and healthcare executives about the industry's digital transformation.

Technology

In a big-data age, drug development needs to be reinvented. The data revolution is already taking place in finance and commerce, in agriculture and transportation. There’s no reason for pharma to stay behind. “Tech on Drugs” is a podcast about the future of pharma. From novel targets to novel biomarkers. From disease models to population models. From clinical trials to synthetic trials. It’s a show about the doctor in the clinic who needs to build on molecular features and about the bioinformatician in the lab who needs to build on clinical endpoints. In each episode, our host, Prof. Shai Shen-Orr, gets to do what he loves to do most. He gets to speak with some of the world’s top scientists and healthcare executives about the industry's digital transformation.

In a big-data age, drug development needs to be reinvented. The data revolution is already taking place in finance and commerce, in agriculture and transportation. There’s no reason for pharma to stay behind. “Tech on Drugs” is a podcast about the future of pharma. From novel targets to novel biomarkers. From disease models to population models. From clinical trials to synthetic trials. It’s a show about the doctor in the clinic who needs to build on molecular features and about the bioinformatician in the lab who needs to build on clinical endpoints. In each episode, our host, Prof. Shai Shen-Orr, gets to do what he loves to do most. He gets to speak with some of the world’s top scientists and healthcare executives about the industry's digital transformation.

Share Season 3 - Episode 2 - The Single Cell Revolution - Prof. Fabian Theis

Sign up to save your podcasts

Season 3 - Episode 2 - The Single Cell Revolution - Prof. Fabian Theis

Season 3 - Episode 2 - The Single Cell Revolution - Prof. Fabian Theis

More shows like Tech on Drugs with Shai Shen-Orr

Freakonomics Radio

All-In with Chamath, Jason, Sacks & Friedberg

Call Me Back - with Dan Senor

Huberman Lab